H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Census population 134,023. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Haven clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Haven storefront.
Biologic Therapy for Osteoarthritis in New Haven, CT for clinics & physicians. Biologic therapy options fo… Compliance support & pricing — contact Hawk Medical.
14.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Population 134,023. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JK documentation are ready before the first application of osteoarthritis biologic therapy.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)14.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 134,023 residents will still mix those payers. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for New Haven.
CDC PLACES (2023, crude prevalence) estimates 11.7% of adults — 0.3 points below the U.S. 12% figure. Obesity is 37.9%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a New Haven trial.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a New Haven medical practice or that we hold a local facility license.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Connecticut clinician.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 11.7% diabetes and 20.3% arthritis for New Haven — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in New Haven, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Haven is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Haven — 0.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Haven. Useful for joint-program math; still needs a diagnosis and privileging.
No New Haven storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.